The ROC curve analysis of IL-13 for the diagnosis of MCI in the NAFLD patients showed an AUC value of 0.804 (95% confidence interval 0.680–0.928; p < 0.0001) (Figure S2). Here, IL13 is linked to metabolic dysfunction-associated steatotic liver disease.